By coating tiny gel beads with lung-derived stem cells and then allowing them to self-assemble into the shapes of the air sacs found in human lungs, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have succeeded in creating three-dimensional lung “organoids.” The laboratory-grown lung-like tissue can be used to study diseases including idiopathic pulmonary fibrosis, which has traditionally been difficult to study using conventional methods.
“While we haven’t built a fully functional lung, we’ve been able to take lung cells and place them in the correct geometrical spacing and pattern to mimic a human lung,” said Dr. Brigitte Gomperts, an associate professor of pediatric hematology/oncology and the study’s lead author.
Idiopathic pulmonary fibrosis is a chronic lung disease characterized by scarring of the lungs. The scarring makes the lungs thick and stiff, which over time results in progressively worsening shortness of breath and lack of oxygen to the brain and vital organs. After diagnosis, most people with the disease live about three to five years. Though researchers do not know what causes idiopathic pulmonary fibrosis in all cases, for a small percentage of people it runs in their families. Additionally, cigarette smoking and exposure to certain types of dust can increase the risk of developing the disease.
To study the effect of genetic mutations or drugs on lung cells, researchers have previously relied on two-dimensional cultures of the cells. But when they take cells from people with idiopathic pulmonary fibrosis and grow them on these flat cultures, the cells appear healthy. “Scientists have really not been able to model lung scarring in a dish,” said Gomperts, who is a member of the UCLA Broad Stem Cell Research Center. The inability to model idiopathic pulmonary fibrosis in the laboratory makes it difficult to study the biology of the disease and design possible treatments.
Gomperts and her colleagues started with stem cells created using cells from adult lungs. They used those cells to coat sticky hydrogel beads, and then they partitioned these beads into small wells, each only 7 millimeters across. Inside each well, the lung cells grew around the beads, which linked them and formed an evenly distributed three-dimensional pattern. To show that these tiny organoids mimicked the structure of actual lungs, the researchers compared the lab-grown tissues with real sections of human lung.
“The technique is very simple,” said Dan Wilkinson, a graduate student in the department of materials science and engineering and the paper’s first author. “We can make thousands of reproducible pieces of tissue that resemble lung and contain patient-specific cells.”
Moreover, when Wilkinson and Gomperts added certain molecular factors to the 3-D cultures, the lungs developed scars similar to those seen in the lungs of people who have idiopathic pulmonary fibrosis, something that could not be accomplished using two-dimensional cultures of these cells.
Using the new lung organoids, researchers will be able to study the biological underpinnings of lung diseases including idiopathic pulmonary fibrosis, and also test possible treatments for the diseases. To study an individual’s disease, or what drugs might work best in their case, clinicians could collect cells from the person, turn them into stem cells, coax those stem cells to differentiate into lung cells, then use those cells in 3-D cultures. Because it’s so easy to create many tiny organoids at once, researchers could screen the effect of many drugs. “This is the basis for precision medicine and personalized treatments,” Gomperts said.
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Leukemia Protein Atlas Holds Power to Accelerate Precision Medicine on April 17, 2019 at 7:15 am
Statistics can be a great tool for analyzing datasets and it can also be a sobering means to provide a stark reality. For instance, recent data suggests that approximately every three minutes one ... […]
- The Latin America precision medicine market is expected to expand at a CAGR of 9.35% leading to a revenue of USD 6.48 Bn by 2023 on April 17, 2019 at 6:22 am
Precision medicine is a combination of molecular biology techniques and system biology. Big data analytics is expected to drive the market in Latin America. Latin American countries like Brazil, ... […]
- Can precision medicine keep Singapore ahead in advanced care? on April 16, 2019 at 11:02 pm
However, now the medical community is quickly realising that cancer is far more complex than a single disease. For example, even if a tumour is in the same location for two patients, the genetic ... […]
- Sutter Health, UPMC team up on precision medicine to improve multiple sclerosis treatments on April 16, 2019 at 11:48 am
Sutter Health is teaming up with the University of Pittsburgh Medical Center and biomedical informatics and data management company DNAnexus on precision medicine research to develop more personalized ... […]
- U of T launches PRiME, a precision medicine initiative on April 16, 2019 at 9:40 am
“The idea is to bring together the cutting-edge work we are doing in precision medicine and give it a central focus point and vision," said Shana Kelley of U of T’s Leslie Dan Faculty of Pharmacy ... […]
- Collecting health data for ‘precision medicine’ of the future on April 15, 2019 at 7:18 am
ST. LOUIS – Dr. Joan Davis from the Missouri School of Dentistry and Oral Health joins us to promote the "All of Us" research program's health data collection. The organization is sending their ... […]
- A Mathematical Representation of Precision Medicine on April 12, 2019 at 12:00 pm
Diseases most often arise from a confluence of genetic and environmental factors. Precision medicine promises the ability to understand and treat disease in an individualized manner. To fully enable ... […]
- Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative on April 11, 2019 at 6:02 am
Precision Therapeutics' Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients Helomics to provide CRO services and its ... […]
- New cancer drug targets accelerate path to precision medicine on April 10, 2019 at 10:02 am
In one of the largest studies of its kind, researchers used CRISPR technology to disrupt every gene in over 300 cancer models from 30 cancer types and discover thousands of key genes essential for ... […]
via Bing News